Tatva Chintan Pharma Chem share news and announcements
NSE: TATVABSE: 543321Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,664.10.
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,671 Cr999th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 19 Oct 2026
- 58.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 Oct 2026
- 4.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.13%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 19 Oct 2026
- 8.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 19 Oct 2026
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 19 Oct 2026
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,50,09037.5% delivered
Tatva Chintan Pharma Chem analyst meets
106 filed, newest first. Page 1 of 3.
Oct 2026
16 Oct · Analysts
13 Oct · Analysts
Sep 2026
17 Sep · Analysts
8 Sep · Analysts
Aug 2026
7 Aug · Analysts
3 Aug · Analysts
Jul 2026
31 Jul · Analysts
24 Jul · Analysts
24 Jul · Analysts
24 Jul · Analysts
22 Jul · Analysts
21 Jul · Analysts
10 Jul · Analysts
Jun 2026
12 Jun · Analysts
May 2026
6 May · Analysts
Mar 2026
19 Mar · Analysts
14 Mar · Analysts
11 Mar · Analysts
Feb 2026
11 Feb · Analysts
Jan 2026
12 Jan · Analysts
Nov 2025
22 Nov · Analysts
15 Nov · Analysts
11 Nov · Analysts
7 Nov · Analysts
7 Nov · Analysts
7 Nov · Analysts
6 Nov · Analysts
5 Nov · Analysts
Oct 2025
17 Oct · Analysts
Sep 2025
4 Sep · Analysts
4 Sep · Analysts
1 Sep · Analysts
Aug 2025
12 Aug · Analysts
11 Aug · Analysts
Jul 2025
17 Jul · Analysts
Apr 2025
28 Apr · Analysts
25 Apr · Analysts
Mar 2025
24 Mar · Analysts
18 Mar · Analysts
Jan 2025
17 Jan · Analysts
Dec 2024
4 Dec · Analysts
Oct 2024
16 Oct · Analysts
Sep 2024
23 Sep · Analysts
4 Sep · Analysts
Aug 2024
8 Aug · Analysts
Jul 2024
20 Jul · Analysts
Jun 2024
22 Jun · Analysts
10 Jun · Analysts
Apr 2024
27 Apr · Analysts
Mar 2024
26 Mar · Analysts